8-K: NovAccess Global Secures $65,000 Loan and Warrants for Operations and Uplisting

NovAccess Global Inc. has entered into a securities purchase agreement for a $65,000 loan, issuing a promissory note and warrants to AJB Capital Investments, LLC, to fund debt repayment, operations, and the filing of its June 30, 2024, quarterly report.

Summary

• NovAccess Global Inc. secured a $65,000 loan from AJB Capital Investments, LLC, through a securities purchase agreement.
• The loan includes a 10% original issuance discount, resulting in net proceeds of $58,500, and carries a 12% annual interest rate.
• The promissory note is due on March 18, 2025, and must be repaid from the proceeds of an offering exceeding $5.0 million in connection with an uplisting to a national securities exchange.
• The company also issued warrants to AJB to purchase two million shares of common stock at $0.0001 per share.
• NovAccess is required to file a Form S-1 by December 17, 2024, to register the shares issuable upon conversion of the note and exercise of the warrants.
• The loan proceeds will be used for debt repayment, operations, and to cover expenses related to filing the company's June 30, 2024, quarterly report.
• The company expects to file the June 10-Q in October.
• A previous loan of $33,340 was also obtained from AJB on similar terms on August 16, 2024, with one million shares issued as a commitment fee.

Sentiment

Score: 3

Explanation: The document indicates a high-risk situation for NovAccess. While the loan provides necessary capital, the high interest rate, restrictive covenants, and reliance on a future uplisting for repayment suggest significant financial challenges and potential downside for investors.

Positives

• The loan provides immediate capital for operations and debt repayment.
• The company has the option to prepay the note at any time without penalty.
• The loan includes a path to repayment through a potential uplisting and offering.

Negatives

• The loan has a high interest rate of 12% per annum.
• The company is restricted from selling a significant portion of its assets without AJB's approval.
• The company cannot issue additional debt that is not subordinate to AJB.
• Failure to comply with the loan terms could result in an 18% default interest rate and other penalties.
• A default could lead to the note being multiplied by two as a default penalty.
• The company has granted AJB a security interest in all of its assets, including the equity of StemVax, LLC.

Risks

• Failure to make required payments or comply with covenants could trigger an event of default.
• An event of default could result in an 18% interest rate, immediate acceleration of the note, and conversion of the debt into shares at a discount.
• The company's assets are secured by the loan, increasing the risk to the company if it defaults.
• The company is dependent on a successful uplisting and offering to repay the loan.
• The company is subject to various restrictions and requirements under the terms of the note.

Future Outlook

The company intends to use the loan proceeds to repay debt, fund operations, and file its June 30, 2024, quarterly report. The company is also working towards an uplisting to a national securities exchange, which would trigger a mandatory repayment of the note if the offering exceeds $5.0 million.

Industry Context

This type of financing is common for small companies seeking to raise capital for operations and growth. The use of convertible debt and warrants is a typical structure for such transactions, providing the lender with potential upside while also providing the company with needed capital.

Comparison to Industry Standards

• The interest rate of 12% is relatively high, which is not uncommon for small companies with limited access to traditional financing.
• The use of warrants is a standard practice in these types of transactions, providing the lender with potential equity upside.
• The requirement to repay the loan from proceeds of an uplisting is a common structure for companies seeking to move to a larger exchange.
• The security interest granted to the lender is also a standard practice to protect the lender's investment.

Stakeholder Impact

• Shareholders face potential dilution from the issuance of warrants and conversion of the note.
• Creditors are secured by the company's assets, reducing their risk.
• Employees may be impacted by the company's financial performance and ability to operate.
• Customers and suppliers may be affected by the company's financial stability.

Next Steps

• The company needs to file its June 30, 2024, quarterly report.
• The company needs to file a Form S-1 by December 17, 2024, to register the shares for resale.
• The company needs to pursue an uplisting to a national securities exchange.
• The company needs to manage its debt obligations and comply with the loan covenants.

Key Dates

Keywords

loan, promissory note, warrants, securities purchase agreement, AJB Capital Investments, uplisting, debt repayment, Form S-1, common stock, interest rate